Vzarii Therapeutics

Vzarii Therapeutics

Developing innovative gene therapy platform technologies targeting mitochondrial dysfunction 🧬.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round

$100k

-
Total Funding000k
More about Vzarii Therapeutics
Edit

Our company name, Vzarii, pronounced ‘va-za-ri’ is derived from the Latin word ‘versare’ meaning ‘to engage’ and captures our belief that ‘restoring’ mitochondrial function will have a positive impact on neurodegenerative diseases. It also reflects our commitment to ‘collaborate’ with like-minded partners and healthcare providers to bring our novel gene therapy solutions to patients.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads